Bioatla Inc

Stock Chart, Company Information, and Scan Results

$0.35(as of Aug 5, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bioatla Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$0.35
Ticker SymbolBCAB
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees61
CountyUSA
Market Cap$19.4M
EBIDTA-66.2M
10-Day Moving Average0.36
P/E Ratio-0.33
20-Day Moving Average0.37
Forward P/E Ratio0.00
50-Day Moving Average0.40
Earnings per Share-1.23
200-Day Moving Average0.72
Profit Margin-Infinity%
RSI44.75
Shares Outstanding58.4M
ATR0.03
52-Week High2.53
Volume347,662
52-Week Low0.24
Most Recent Support Level0.33
Book Value0.5M
Most Recent Resistance Level0.37
P/B Ratio37.27
Upper Keltner0.44
P/S Ratio1.85
Lower Keltner0.29
Debt-to-Equity Ratio0.44
Next Earnings Date08/07/2025
Cash Surplus16.4M
Next Ex-Dividend DateUnknown

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma of head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.

Bioatla Inc In Our Stock Scanner

As of Aug 06, 2025
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.